Arctic Bioscience AS
OSE:ABS
Decide at what price you'd be comfortable buying and we'll help you stay ready.
Intrinsic Value
The intrinsic value of Arctic Bioscience AS (ABS) under the Base Case is 4.4 NOK per share. Compared with the current market price of 2.3 NOK, the stock appears Undervalued by 48% .
The intrinsic value is calculated using the DCF method. Operating margin recovers from -83% last year to -33% by 2033. Revenue grows about 22% a year over the next five years, above its five-year pace of 14%. The forecast years subtract value, so the estimate rests entirely on the years after 2033.
Do our valuations actually work? See backtest results .
Cheap or expensive for this stock?
This block shows whether today’s valuation is cheap or expensive compared with the stock’s own history, and what happened after similar valuations in the past.
We compare the gap between the stock’s price and our estimated value over time.
- Undervalued can still be historically expensive. The stock may trade below our estimated value, but usually offer an even bigger discount.
- Overvalued can still be historically cheap. The stock may trade above our estimated value, but usually carry an even higher premium.
Market expectations can differ from our model, which may not fully capture everything affecting the price. That is why some stocks regularly trade above our estimated value and others below it.
The scale and chart show how today’s valuation compares with the past. The cards summarize past returns and waiting times until the stock stopped being cheap or expensive. This can happen because the price changed, our estimated value changed, or both.
Only completed periods are included. These are past results, not forecasts. The usual historical range does not necessarily mean fair value.
Fundamental Analysis
What Arctic Bioscience AS Does
Arctic Bioscience AS engages in the development, manufacturing, and marketing of marine ingredients extracted from herring roe. The company is headquartered in Orsta, More Og Romsdal. The company went IPO on 2021-02-24. Arctic Bioscience’s purpose is to provide people with autoimmune disorders an effective and healthy therapy based on marine membrane lipids. The firm is developing HRO350 - a novel investigational drug candidate.
- Headquarters
- Norway NO
- IPO date
- Feb 24, 2021
Earnings Waterfall
Arctic Bioscience AS
What is the Intrinsic Value of one ABS stock?
The intrinsic value for Arctic Bioscience AS (ABS) under the Base Case is 4.4 NOK.
Is ABS stock undervalued or overvalued?
Compared with the current market price of 2.3 NOK, the stock appears Undervalued by 48% .